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Abstract
Background: The PTEN phosphatase acts on phosphatidylinositol 3,4,5-triphosphates resulting from phosphatidylinositol 3-
kinase (PI3K) activation. PTEN expression has been shown to be decreased in colorectal cancer. Little is known however as to
the specific cellular role of PTEN in human intestinal epithelial cells. The aim of this study was to investigate the role of PTEN
in human colorectal cancer cells.
Methodology/Principal Findings: Caco-2/15, HCT116 and CT26 cells were infected with recombinant lentiviruses
expressing a shRNA specifically designed to knock-down PTEN. The impact of PTEN downregulation was analyzed on cell
polarization and differentiation, intercellular junction integrity (expression of cell-cell adhesion proteins, barrier function),
migration (wound assay), invasion (matrigel-coated transwells) and on tumor and metastasis formation in mice. Electron
microscopy analysis showed that lentiviral infection of PTEN shRNA significantly inhibited Caco-2/15 cell polarization,
functional differentiation and brush border development. A strong reduction in claudin 1, 3, 4 and 8 was also observed as
well as a decrease in transepithelial resistance. Loss of PTEN expression increased the spreading, migration and invasion
capacities of colorectal cancer cells in vitro. PTEN downregulation also increased tumor size following subcutaneous
injection of colorectal cancer cells in nude mice. Finally, loss of PTEN expression in HCT116 and CT26, but not in Caco-2/15,
led to an increase in their metastatic potential following tail-vein injections in mice.
Conclusions/Significance: Altogether, these results indicate that PTEN controls cellular polarity, establishment of cell-cell
junctions, paracellular permeability, migration and tumorigenic/metastatic potential of human colorectal cancer cells.
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Introduction
Colorectal cancer (CRC) is the second leading cause of cancer-
related death in Western countries. A hallmark of colorectal
cancer is loss of cellular organization. The histological grade of
colorectal carcinomas is an important prognostic variable and is
dependent on the degree of glandular differentiation and cellular
polarity. High-grade, poorly differentiated colorectal neoplasms
are usually more aggressive than their low-grade, well-differenti-
ated counterparts [1].
In epithelial cells, cell-cell adhesion and apical-basal polarity are
maintained through the formation of several intercellular adhesion
systems such as tight junctions (TJs). The TJ regulates paracellular
diffusion and functionally segregates the plasma membrane into
two compartments, which is a requirement for full polarization of
epithelial cells [2]. Neoplastic cells frequently exhibit structural
and functional deficiencies in both tight and adherent junctions
[3–5]. As reviewed by Martin and Jiang [4], the expression of
many tight junction proteins is disregulated in colorectal cancers.
The adherens junction protein E-cadherin is also diminished in
invasive colorectal cancers [6]. Additionally, the expression
pattern of hDlg and hScribble, known to control the establishment
of apical-basal polarity in epithelial cells [7], markedly changes
during colorectal tumor progression with down-regulation of both
proteins being associated with lack of epithelial cell polarity and
disorganized tissue architecture [8].
Phosphoinositides have also emerged in recent years as general
determinants of both polarity and identity of several membranes.
Recent data indicate that PtdIns(4,5)P2 is a key determinant of the
apical surface in epithelial cells [9]. Indeed, in non-polarized
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cell-cell and cell-extracellular matrix contacts. However, during
the early stages of polarization, PtdIns(4,5)P2 becomes mostly
concentrated at the apical membrane of the cells whereas
PtdIns(3,4,5)P3 remains localized to the basolateral membrane
and excluded from the apical membrane. The lipid phosphatase
PTEN localizes to the apical domain and is essential for the
segregation of PtdIns(4,5)P2 to the apical surface due to its
dephosphorylating action on the D3-phosphate group of
PtdIns(3,4,5)P3 [10]. Furthermore, PTEN acts as a negative
regulator of the Phosphatidyl Inositol 3-Kinase (PI3K)/Akt
signaling pathway and has been shown to influence many
processes deregulated in tumorigenesis such as proliferation, cell
survival, migration and invasion [11,12].
PTEN is encoded by the phosphatase and tensin homolog deleted on
chromosome 10 (pten) tumor suppressor gene, which is the second
most frequently mutated gene in human cancers following TP53
[12]. Furthermore, loss of PTEN immunostaining in colorectal
cancers tissues has been associated with advanced disease, liver
metastasis and poor patient survival [13–16], suggesting its
potential protecting role against progression of human colorectal
carcinogenesis. Since PTEN controls polarity in normal epithelial
cells, one might speculate that the loss of this protein may be
sufficient to trigger epithelial-mesenchymal transition (EMT), a
critical early event in the invasion and metastasis of many types of
cancer, including CRC. In previous studies, the effects of PTEN
loss have primarily been measured in cancer cell lines which
harbor numerous other transforming and oncogenic mutations
and which have lost their epithelial phenotype [17–19]. Such an
approach has made it difficult to determine which phenotypes are
directly conferred by the loss of PTEN and for defining the stages
of tumorigenesis that are specifically altered in cells with PTEN
loss. In order to further characterize the link between PTEN loss,
loss of polarity and colorectal cancer progression, we used the
Caco-2/15 cell line derived from a relatively well-differentiated
human colorectal adenocarcinoma. This clone of the parent Caco-
2 cell line has been extensively characterized for its ability to
undertake a full morphological and functional intestinal epithelial
differentiation process which takes place spontaneously once
confluence has been reached and which is completed after 15–
20 days of post-confluence. More specifically, these colonic cells
form apical tight and adherent junctional complexes and form a
polarized monolayer after several days of post-confluence,
exhibiting transepithelial electric resistance (TEER) similar to in
vivo observations [20–22]. The following ‘‘de-differentiated’’ CRC
cell lines were also analyzed: the HCT116, a microsatellite-
unstable human CRC cell line and CT26, a mouse metastatic
colon carcinoma cell line. Results show that PTEN may act as a
barrier to cancer development by controlling cellular polarity,
establishment of cell-cell junctions, paracellular permeability,
migration and metastatic potential of human colorectal cancer
cells.
Materials and Methods
Material and antibodies
The antibodies for detection of PTEN (A2B1), HNF1a (C-19)
and HNF4a (C-19) were purchased from Santa Cruz Biotechnol-
ogy (Santa Cruz, CA). Antibodies raised against E-cadherin and
villin were from BD Biosciences (Mississauga, ON, Canada). The
antibodies for detection of phospho-AKT (Ser473) and AKT were
from Cell Signaling Technology (Danvers, MA). The b-actin
antibody was from Chemicon (Temecula, CA). The occludin,
claudins and the ZO-1 antibodies were all from Zymed
Laboratories (Invitrogen, Burlington, ON, Canada). Monoclonal
antibody HSI-14 against sucrase-isomaltase was kindly provided
by Dr Andrea Quaroni (Cornell University, Ithaca, NY). CDX2
immunoblotting was performed with a rabbit polyclonal antibody
against CDX2 previously characterized [23]. All other materials
were obtained from Sigma-Aldrich (Oakville, ON) unless stated
otherwise.
Cell culture
Three colon cancer cell lines were used in the present study:
1-The colorectal adenocarcinoma cell line Caco-2/15 was
obtained from A. Quaroni (Cornell University, Ithaca, NY). This
cell line provides a unique and well characterized model for the
study of gut epithelial differentiation since these cells undergo
functional and morphological differentiation to an enterocyte
phenotype with microvilli, dome formation, and expression of
sucrase-isomaltase several days after reaching confluence [20–22].
These cells express truncated APC and mutated p53 but exhibit
wild-type K-Ras, b-catenin and mismatch repair (MMR) proteins;
they are therefore microsatellite stable (MSS) [24,25]. These cells
were cultured in Dulbecco’s modified Eagle’s medium (DMEM,
Invitrogen
TM) containing 10% fetal bovine serum (FBS). 2- The
HCT116 cells were obtained from ATCC (CCL-247). These cells
grow in multi-layers and are incapable of polarization or intestinal
epithelial differentiation [20]. These cells are hMLH1-deficient,
express wild-type p53, wild-type APC and carry activating K-Ras,
pi3kca, and b-catenin mutations [26]. These cells are metastatic
[27,28] allowing us to analyse the impact of PTEN loss of
expression in advanced stages of colorectal cancer. These cells
were cultured in McCoy’s medium (Wisent, St-Bruno, Que ´bec,
Canada) containing 10% FBS. 3- CT26 cells (kindly provided by
Pr Nicole Beauchemin, Universite ´ McGill, Canada) were derived
from an undifferentiated murine adenocarcinoma which was
induced by rectal injection of N-nitroso-N-methylurethane in
Balb/c mice. These cells carry activating K-Ras mutations [29],
wild-type p53 and do not express E-cadherin or ZO-1 [30]. CT26
cells were maintained in RPMI medium (Invitrogen
TM) containing
10% FBS and penicillin-streptomycin.
Plasmid constructions and lentiviruses production
The lentiviral shRNA expression vector (pLenti6-U6) was
constructed as previously described [31]. ShRNA oligonucleotides
against human PTEN were designed according to Ambion
guidelines (technical bulletin #506) using the siRNA sequences
gctaagtgaagatgacaatca (#1), gcacaagaggccctagatttc (#2), gccagc-
taaaggtgaagatat (#3) with ttcaagaga as the loop sequence. The
oligonucleotide-annealed products were subcloned into pLenti6-
U6 between the BamHI and XhoI sites. An irrelevant pLenti-
shGFP (gccacaacgtctatatcatgg) or a mutated pLenti-shPTEN
(shMUT) was used as negative control. The mutated pLenti-
shPTEN was generated by changing 3 nucleotides in the sequence
of the most efficient shRNA against PTEN (#2) resulting in the
siRNA sequence gcacaagataacctagatttc. The shRNA against the
murine form of Pten (TRCN0000028992) and a corresponding
control shRNA (shTGFP) against TurboGFP
TM (SHC004) were
obtained from Sigma-Aldrich. Lentiviruses produced in 293T cells
were used for cell infection according to Invitrogen recommen-
dations (ViraPower Lentiviral Expression System). No induction of
OAS1 gene expression was detected by Q-PCR analysis in the
experiments involving lentiviruses infection (data not shown).
OAS1 (2050-oligoadenylate synthetase) is a classic interferon target
gene and has been recommended as a key test for interferon
induction before attributing a particular response to the gene
targeted [32].
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Protein extractions and Western blot analysis were performed as
previously described [22].
Transmission electron microscopy
Samples were processed as previously described [22] and
observed on a Hitachi H-7500 transmission electron microscope.
Scanning electron microscopy
The Caco-2/15 cells were seeded on small lamellae of 12 mm in
diameter and fixed as previously described for transmission
electron microscopy [22] up to the dehydration step in ethanol.
Samples were then critical-point dried with CO2 and covered with
gold-palladium with a sputter coater. Coated cells were subse-
quently observed with a JEOL scanning electron microscope
(model: JSM-840).
Determination of transepithelial electric resistance
Caco-2/15 cells were plated on TranswellH permeable mem-
branes (Corning, Acton, MA). TEER were measured 3 and 9 days
after the cells had reached confluence with an epithelial
Voltommeter (World Precision Instrument, model EVOM-G).
RNA analysis
Total RNA isolation, RT-PCR and Q-PCRs were performed as
previously described [31]. Target expression was quantified
relatively to PDGB expression. Primers for each gene were
designed at exon-exon junctions using the Primer3 software [33].
Primer sequences and Q-PCR conditions are available on request.
Migration assays
The assays were performed according to the sharp razor blade
technique as previously reported [34].
Assays of Rac and Cdc42 activities
GTP-bound levels of Rac and Cdc42 were analyzed with a G-
LISA activation assay biochemistry kit (Cytoskeleton, Denver,
CO) according to the manufacturer’s instructions.
Invasion assays
Invasion assays were performed using BD BioCoat
TM Ma-
trigel
TM Invasion Chambers with 8-mm polycarbonated filters (BD
Biosciences). Cells were seeded in media without serum in the
presence of 2 mM hydroxyurea, a pharmacological inhibitor of
cellular ribonucleoside reductase to arrest the cell cycle in G1/S
phase [35]. Media containing 20% FBS was used as chemoat-
tractant. After an incubation of 48 h at 37uC, non-invasive cells
were removed according to the manufacturer’s procedure and
invading cells were fixed with methanol 100%. Cells were then
stained in crystal violet 1%.
Animal models
Female nude mice CD1 nu/nu and Fox Chase SCID Beige mice
were purchased from Charles River (Wilmington, MA). All
experimental protocols were approved by the Ethics Committee
for Animal Experimentation of the Universite ´ de Sherbrooke.
Tumor growth: A total of 2610
6 cells suspended in 100 ml DMEM
were injected into the dorsal subcutaneous tissue of 5-week-old
female mice CD1 nu/nu. Mice were sacrificed after 42 days post-
injection for Caco-2/15 and 30 days post-injection for HCT116.
Tumors were excised and weighed. Experimental tail vein assays: The
tail-vein of 5-week-old female CD1 nu/nu mice or Fox Chase
SCID Beige mice was injected with 10
6 Caco-2/15, HCT116 or
CT26 cells suspended in 100 ml DMEM. Animals were sacrificed
at any sign of respiratory distress or weight loss, or after 14 days
post-injection for CT26, 75 and 35 days post-injection for
HCT116 injected respectively in CD1 nu/nu and Fox Chase
SCID Beige mice and 60 days post-injection for Caco-2/15 cells
injected in Fox Chase SCID Beige mice. Lungs were maintained
in Bouin’s fixative for 24 h. Individual lobes were then separated
and the total number of surface-visible metastases was determined.
Human tumors
Samples of colon cancers and paired normal colon tissues (at
least 10 cm from the tumor) have been obtained from patients
undergoing surgical resection. Patients did not receive neoadju-
vant chemotherapy or radiotherapy. Tissues were obtained after
patient’s written informed consent, according to the protocol
approved by the Institutional Human Subject Review Board of the
Centre Hospitalier Universitaire de Sherbrooke. Clinical and
pathological informations were obtained from medical records.
Adenoma samples were endoscopically unresectable and defined
as advanced because of their size larger than 1 cm or by the
presence of high-grade dysplasia or villous component. Patient’s
cancers were histologically classified and graded according to
overall TNM staging criteria (based on Tumor-, lymph Node- and
Metastatic- status). All tissues were frozen in liquid nitrogen within
15 min from resection as recommended by the Canadian Tumor
Repository Network (www.ctrnet.ca). For protein extraction,
paired tissues were lysed in Triton sample buffer (100 mM NaCl,
5 mM EDTA [pH 8.0], 50 mM Tris–HCl [pH 7.5], 1% Triton
X-100, 5% glycerol, 1 mM PMSF, 0.2 mM orthovanadate,
40 mM b-glycerophosphate, 50 mM NaF, and 2% protease
inhibitor cocktail [P 8340, Sigma-Aldrich]) and immunoblotted
as previously described [22].
Data presentation
Typical results shown are representative of 3 independent
experiments. Statistics were calculated using Student two tailed
t-test. Differences were considered significant at * p#0.05 or
*** p#0.005. Densitometric analyses were performed using Image
J software.
Results
PTEN controls colonic epithelial cell polarization and
differentiation
To investigate the impact of PTEN loss of expression on
differentiation and polarization of colorectal cancer cells, recom-
binant lentiviruses encoding short hairpin RNAs (shRNAs) were
first developed in order to stably suppress PTEN mRNA levels in
Caco-2/15 cells. Several lentiviral constructs were tested for their
ability to knock-down PTEN. The most efficient shRNA was
designated shPTEN (data not shown). Caco-2/15 cells were
henceforth infected with shPTEN lentiviruses or with irrelevant
shGFP lentiviruses or lentiviruses expressing a shPTEN with 3
mismatch nucleotides (shMUT) as negative controls. The pLenti6-
U6 lentiviral vector, which coexpresses a blasticidin S resistance
gene, allowed the selection of pure populations of transduced cells
within 7 days. As shown in Figure 1A, PTEN protein levels were
almost completely knocked-down in Caco-2/15 cells expressing
the shPTEN (.90%); this reduction was maintained during post-
confluency. Of note, PTEN down-regulation was also associated
with an increase in AKT phosphorylation, the main downstream
effector of PI3K, confirming that the PI3K pathway was activated
in shPTEN expressing-cells.
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polarization, cell morphology was first examined at different days
of confluence. As observed by optical microscopy, cell superficy
was significantly increased by 5.3-fold (p,0.005 analyzed by
Metamorph software) in newly confluent Caco-2/15 cells
expressing shPTEN compared to control cells (Figure 1B, left
panels). In addition, transmission electron microscopy analysis
showed that newly confluent control cells had already begun to
polarize whereas PTEN-deficient cells still maintained a flattened
appearance (Figure 1B, middle panels). At 3 days post-confluence,
cells with reduced PTEN expression only started to polarize while
control cells had already gained their cylindrical shape (data not
shown). Down-regulation of PTEN also resulted in a decreased
number of microvilli at the cell apical membrane as observed by
scanning electron microscopy (Figure 1B, right panels). Of note,
expression levels of the functional differentiation markers sucrase-
isomaltase and villin were also markedly diminished in PTEN-
depleted cells (Figure 1C).
We next verified if PTEN silencing alters the expression of
Hepatocyte nuclear factors 1a (HNF1a) and 4 (HNF4a) as well as
caudal-related homeobox transcription factor 2 (Cdx2) which are
known to control intestinal epithelial cell differentiation [36]. As
shown in Figure 1C, while expression levels of HNF4a were
modestly reduced in confluent PTEN-deficient Caco-2/15 cells,
expression of HNF1a and Cdx2 was markedly decreased
(Figure 1C). Taken together, these results indicate that PTEN is
important for epithelial cell polarization as well as functional and
morphological differentiation of intestinal epithelial cells. Of note,
Figure 1. PTEN down-regulation impairs intestinal epithelial cell polarization and differentiation. Caco-2/15 cells were infected with
either recombinant lentiviruses encoding a shRNA which specifically knocks-down PTEN (shPTEN) or negative control shRNAs (shGFP or shMUT). A
and C. After selection of infected cells, Caco-2/15 were lysed at 22, 0, 3, 6, 9 and 12 days post-confluence. Proteins were then analyzed by Western
blot. B. Left panels: Newly confluent Caco-2/15 cells expressing shGFP or shPTEN were observed by optical microscopy. Scale bars =100 mm. Middle
panels: Newly confluent Caco-2/15 cells expressing shGFP or shPTEN were fixed and observed by transmission electron microscopy. Scale bars
=2mm. Right panels: Newly confluent shGFP or shPTEN expressing-cells were observed by scanning electron microscopy. Scale bars =1 mm.
doi:10.1371/journal.pone.0015742.g001
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alteration in cell proliferation since Caco-2/15 cells expressing
shPTEN exhibited the same proliferation rate than control cells
and stop to proliferate as soon as they reached confluence (data
not shown).
PTEN down-regulation impairs tight junction integrity in
colon epithelial cells
Since intercellular junctions are regulators of cell polarity [2,5],
we next verified whether the expression of shPTEN had an effect
on cell junctions. Under transmission electron microscopy,
adherens junctions appeared unaltered (Figure 2A, arrows) in
PTEN-deficient Caco-2/15 cells while tight junctions appeared
less organized at 3 days post-confluence (Figure 2A, brackets). As a
matter of fact, unstructured mass of proteins were systematically
observed without tightening of the membrane at the usual position
of tight junctions. Accordingly, the barrier function of tight
junctions was also compromised as witnessed by the decrease in
TEER measured in shPTEN-expressing cells compared to control
cells at 3 and 9 days post-confluence (Figure 2B). In order to gain
further insight into the manner by which PTEN controls junction
integrity, expression levels of several key junctional proteins such
as occludin, ZO-1 and claudins [2] were analyzed. Protein
expression of claudins 1, 3, 4 and 8 was significantly decreased in
both subconfluent and post-confluent shPTEN cells (Figure 2C).
Of note, expression of the adherens junction protein E-cadherin
was also attenuated in post-confluent shPTEN cells (Figure 2C).
Loss of PTEN expression in Caco-2/15 cells stimulates
migration/invasion, promotes tumor growth but is not
sufficient to confer metastatic potential in vivo
Loss of intercellular junctions is well known to be associated
with increased cell migration and invasion capacities [4].
Furthermore, PTEN has been shown to control such processes
in other cell types [11]. Using the wound-closure assays, the
migration of newly confluent control cells was compared with that
of shPTEN-expressing populations. As shown in Figure 3A, the
ability of shPTEN-expressing Caco-2/15 cells to migrate was
markedly increased compared to control cells, as determined by
measuring the relative area covered by migrating cells. We also
observed that down-regulation of PTEN markedly stimulated
Caco-2/15 cell detachment after trypsinization (data not shown).
These data indicate that PTEN gene transcript silencing in CRC
cells enhances their capacity to spread and migrate. Since PTEN
has been shown to influence migration through the activation of
the small GTPases Rac1 and Cdc42 [37], we next analyzed
whether their respective expression and activity was affected by
loss of PTEN expression. As shown in Figure 3B, both Rac and
Cdc42 displayed higher GTP-bound levels in subconfluent and
confluent shPTEN-expressing cells compared with control cells.
The effect of PTEN deficiency on invasion was also determined
using BD Biocoat Matrigel invasion chambers. As shown in
Figure 3C, Caco-2/15 cells expressing the shPTEN clearly
exhibited increased invasive capacities in comparison to
shMUT-expressing cells. Invasion not only involves breakdown
of cell-cell junctions and increased motility of tumor cells but also
focal proteolysis of the extracellular matrix. As shown in Figure 3D,
Q-PCR analyses revealed that expression levels of matrix
metalloproteinases 2 and 9 (MMP2 and MMP9), osteopontin
(OPN) and uPA (urokinase-type plasminogen activator) were
significantly up-regulated in shPTEN-expressing Caco-2/15 cells.
The tumorigenicity of Caco-2/15 cell populations was next
assessed following subcutaneous injection into the flank of nude
Figure 2. PTEN regulates tight junction integrity and function.
A. Caco-2/15 cells expressing shMUT or shPTEN were fixed after 3 days
post-confluence and observed by transmission electron microscopy.
Scale bars =500 nm. Arrows indicate adherens junctions while
brackets indicate tight junctions. B. Caco-2/15 cells were cultivated
on porous membranes after which transepithelial resistance was
measured in triplicate 3 and 9 days after the cells reached confluence.
*** Significantly different at p#0.005 (Student’s t-test). C. Caco-2/15
cells expressing shGFP or shPTEN were lysed at -2, 0, 3, 6, 9 and 12
days post-confluence followed by Western blot analysis of junctional
proteins.
doi:10.1371/journal.pone.0015742.g002
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PLoS ONE | www.plosone.org 5 December 2010 | Volume 5 | Issue 12 | e15742Figure 3. PTEN down-regulation in Caco-2/15 increases migration/invasion capacity and tumorigenic potential. A. Left panels: Cell
morphology was analyzed by phase contrast microscopy at subconfluence. Right panels: Newly confluent cells stably expressing shMUT or shPTEN
were wounded and treated with 2 mM hydroxyurea. After 48 h, movement of the coherent sheet across the linear wound margin (white line) was
evaluated by phase contrast microscopy. The graph on the right illustrates the relative area covered by migrating cells as assessed on 5 different
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expression in Caco-2/15 cells severely increased their capacity
to induce tumors in vivo.
Finally, we investigated whether PTEN reduction in Caco-2/15
cells is sufficient to induce tumor metastasis in vivo, through the use
of experimental metastasis tail vein assay. Fox Chase SCID Beige
mice injected with control or PTEN-deficient Caco-2/15 cells into
the tail vein failed to develop metastases even at 60 days after
injection (data not shown), indicating that PTEN downregulation
is not sufficient to confer a metastatic potential to well-
differentiated CRC cells.
Loss of PTEN expression stimulates migration/invasion,
enhances tumor growth and induces metastatic
potential of HCT116 cells in vivo
The impact of PTEN silencing was also assessed in the
microsatellite-unstable dedifferentiated cell line HCT116. In these
cells, PTEN silencing also resulted in enhanced phospho-Akt
(Figure 4A), enhanced capacity of both migration upon wound-
ing (Figure 4B) and invasion (Figure 4C), in addition to being
associated with a significant increase in Rac activity (1.5-fold,
p,0.005) and OPN expression (1.9-fold, p,0.005) (data not
shown). Of note, expression levels of MMP-2, MMP-9 and uPA in
control HCT116 cells were already markedly elevated and PTEN
silencing did not further enhance mRNA levels of these molecules
(data not shown). The tumorigenicity of HCT116 cell populations
was also assessed following subcutaneous injection into the flank of
nude mice. As shown in Figure 4D, down-regulation of PTEN
expression in HCT116 cells increased their capacity to induce
tumors in vivo.
Finally, we investigated whether PTEN reduction in HCT116
cells is sufficient to induce tumor metastasis in vivo, through the use
of tail vein assay. After 75 days post-injection, none of the mice
injected with control cells exhibited tumors at necropsy, while
25% of the mice having received cells expressing shRNA against
PTEN developed tumors in various locations such as the heart
and dorsal muscles (Figure 5A). This pattern of ‘‘multi-location’’
metastases has previously been reported with HCT116 clones
expressing pi3kca mutant [38]. In addition, preliminary results
obtained with Fox Chase SCID Beige mice, which are more
succeptible to metastases development, suggest that injection of
PTEN-deficient cells in these mice results in much more
pulmonary and ‘‘multi-location’’ metastases than injection of
control HCT116 cells (data not shown). Experiments were also
conducted using the mouse metastatic colon carcinoma cell line
CT26 in order to verify whether PTEN silencing also enhanced
their capacity to develop lung metastasis in allogeneic mice.
Reduction of PTEN expression (Figure 5B) in these cells also
resulted in enhanced expression levels of phosphorylated Akt (not
shown). Importantly, PTEN silencing in CT26 cells significantly
increased their capacity to develop metastases in the lung (.3-
fold) after their injection into the tail vein within 14 days
(Figure 5B). Thus, these data suggest that PTEN downregulation
does enhance the metastatic potential of CRC cells which have
already acquired metastatic properties.
PTEN protein expression is frequently diminished in
colorectal cancer patients
Although PTEN gene mutations are rare [13,16,39,40], several
studies have reported, by using immunohistochemical detection
methods, a decrease of PTEN expression in colorectal cancer tissues
[14–17,41]. However, some variability in PTEN immunostain-
ing has been observed, with studies reporting either nuclear or
cytoplasmic PTEN localization. Additionally, it has been reported
that some antibodies frequentlyused gave a non-specific PTEN signal
on paraffin-embedded tissues [42]. Therefore, PTEN protein
expression was investigated by Western blot analysis in 53 paired
samples of colon cancer (resection margins and primary tumors). As
observed in Figure 6, relative amounts of PTEN protein were
effectively found to be significantly reduced in these colorectal tumors
compared to corresponding normal specimens (p#0.005, paired
t-test). In fact, expression of PTEN protein was found to be
significantly reduced by 40% in 33/53 tumors (P,0.0001, paired
t-test), regardless of tumor stage and grade (5 to 16 biopsies per stage).
Discussion
Tissue transformation in cancer is frequently associated with
loss of cell and tissue polarity, although the molecular mechanisms
underlying this loss are not known. It is likely that the
transformation process involves alteration in polarity gene
expression and/or their subcellular protein localization resulting
in functional inactivation of polarity pathways [7]. In this respect,
PTEN has recently emerged as a key determinant of epithelial
polarity [9]. Indeed, recent analyses in vivo, in primary cells or
using cultured cells retaining significant cellular architecture and
polarity, have shown that PTEN is enriched at specialized sites, in
particular, at the apical domains of polarized epithelial cells. This
epithelial polarization of PTEN was initially demonstrated in
Drosophila [43,44] and subsequently in the chick embryo epiblast
epithelium [45] as well as in polarized T84 and Caco-2 colon cells
and MDCK kidney cells in 3D culture [46]. Consequently, the
substrate of PTEN, PtdIns(3,4,5)P3, is stably localized at the
basolateral membrane and is excluded from the apical plasma
membrane of epithelial cells [47,48]. Of note, PtdIns(3,4,5)P3 has
been reported to act as a key determinant of the epithelial
basolateral surface in mammalian cells [49]. Addition of
exogenous PtdIns(3,4,5)P3 to the apical surface of filter-grown
MDCK cells causes the relocalization of basolateral proteins to the
apical surface and the removal of apical proteins from the apical
surface [49]. Conversely, growth of MDCK or Caco-2/15 cells in
the presence of low concentrations of inhibitors of PI3K which
convert PtdIns(4,5)P2 to PtdIns(3,4,5)P3, causes the size of the
lateral membrane and the height of the cells to be diminished [22].
Therefore, by controlling the levels of PtdIns(4,5)P2 and
PtdIns(3,4,5)P3, PI3K and PTEN thus stringently control the
signaling from phosphoinositides defining epithelial plasma
membrane identity and epithelial polarity.
There is clear genetic evidence for a central role for both of
these enzymes in tumorigenesis: somatic mutations that target
PTEN and the a catalytic subunit of PI3K (pi3kca) are frequent
occurrences in human cancer, resulting in increased activity of the
wound experiments per condition using Image J software. Scale bars =100 mm. B. Activated levels of GTP-bound Rac or Cdc42 were analyzed with G-
LISA activation assay biochemistry kits on subconfluent (SC) and newly confluent (C) Caco-2/15 cells. C. Invasion of cells was studied using Matrigel-
coated Transwells. After 48 h, invading cells were fixed, stained with crystal violet 1% and counted. D. Subconfluent shMUT and shPTEN-expressing
Caco-2/15 cells were lysed and total RNA isolated for gene expression analyzed by Q-PCRs. The relative level of each RNA was calculated using the
standard curve method and normalized to the corresponding PDGB RNA level. E.2 610
6 proliferating Caco-2/15 cells expressing shMUT or shPTEN
were injected subcutaneously in 5 nude mice per condition. Tumor weight was evaluated 42 days after injection. * p#0.05, *** p#0.005, statistical
differences determined using Student’s t-test.
doi:10.1371/journal.pone.0015742.g003
PTEN Signaling in Colorectal Carcinogenesis
PLoS ONE | www.plosone.org 7 December 2010 | Volume 5 | Issue 12 | e15742PtdIns(3,4,5)P3 signaling pathway [50]. In colorectal cancer
specifically, the pik3ca gene is mutated in 20–25% of CRCs while
pik3ca mutations occurring in the hotspots located in exon 9 and
exon 20 are oncogenic in CRC cell models [51]. Of note, pik3ca
gene abnormalities appear to occur at relatively late stages of
neoplasia, near the time where tumors begin to invade and
metastasize [38]. PTEN mutations are rare in colorectal cancers
[13,16,39,40] although infrequent PTEN mutations in mononu-
cleotide repeat sequences have been reported in sporadic colon
cancers, mainly in association with microsatellite instability [52].
Herein, we observed that PTEN protein expression was decreased
in CRCs in approximately 60% of studied patients, in accordance
with several report based on immunohistochemical detection tools
[14–16]. This suggests that epigenetic mechanisms of PTEN
downregulation are frequent in CRCs [13]. Although this
relationship remains to be elucidated in prospective studies,
reduction of PTEN may be important for the adenoma-colon
cancer sequence.
Herein, through a RNA interference approach, we analyzed the
role of PTEN in the poorly tumorigenic well-differentiated cell line
Caco-2/15, derived from a typical colon adenocarcinoma. Our
data demonstrate that reduction of PTEN expression in these cells
severely impaired their functional polarity which was associated
with reduced levels of tight junction proteins and decreased
transepithelial resistance. In addition, Caco-2/15 cells containing
a low level of PTEN had an enhanced capacity to migrate and
invade in vitro and to form tumors in vivo in nude mice. However,
while PTEN silencing was able to further enhance the metastatic
potential of ‘‘de-differentiated’’ colorectal cancer cells (HCT116
and CT26), it was not sufficient to confer metastatic properties to
Caco-2/15 cells in vivo.
PTEN has previously been shown to interact with cell adhesion
complexes and to stabilize adherens junctions and focal adhesions
thereby allowing a reduction of invasiveness in a range of cancer
cells [53–56]. We show herein that loss of PTEN also impairs the
expression of proteins associated with tight junctions, namely
claudins-1, -3, -4 and -8. Claudins served as the backbone of tight
junctions by forming continuous networks of intramembranous
fibrils (tight junction strands) [2]. This change in expression of
claudins in shPTEN-expressing Caco-2/15 cells was also accom-
panied by a decrease in transepithelial resistance in confluent
monolayers of these cells indicating that PTEN plays a role in the
regulation of intestinal barrier function. However, because
claudins represent a family of more than 20 different four-
transmembrane proteins, we cannot exclude that other claudins
are also modulated by PTEN silencing and contribute to the
observed effect on transepithelial resistance. The molecular
mechanisms by which PTEN affects the expression of these
claudins, and consequently paracellular permeability, are yet
unknown. Previous studies have demonstrated that PTEN
Figure 4. PTEN down-regulation in HCT116 increases migration/invasion capacity and tumorigenic potential. A. HCT116 cells were
infected either with recombinant lentiviruses encoding shMUT or shPTEN. After selection of infected cells, proliferating cells were lysed and protein
expression was analyzed by Western blot. B. Left panels: Cell morphology was analyzed by phase contrast microscopy at subconfluence. Right panels:
Newly confluent cells were wounded and treated with 2 mM hydroxyurea. After 48 h, movement of the coherent sheet across the linear wound
margin (white line) was evaluated by phase contrast microscopy. The graph on the right illustrates the relative area covered by migrating cells as
evaluated on 5 different wound experiments per condition using Image J software. Scale bars =100 mm. C. Invasion of cells was studied using
Matrigel-coated Transwells. After 48 h, invading cells were fixed, stained with crystal violet 1% and counted. D.2 610
6 proliferating HCT116 cells
expressing shMUT or shPTEN were injected subcutaneously in 5 nude mice per condition. Tumor weight was evaluated 30 days after injection.
* Significantly different at p#0.05.
doi:10.1371/journal.pone.0015742.g004
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known to positively regulate gene expression of claudin-2 [59],
claudin-3 and claudin-4 in intestinal epithelial cells [60]. Our data
indicate that Cdx2 as well as HNF1a and HNF4a are significantly
downregulated following PTEN silencing in Caco-2/15. More-
over, HNF4a has been shown to trigger expression of occludin,
claudin-6, claudin-7 in mouse F9 cells [61] and claudin-15 in
mouse intestinal epithelium [62]. More recently, knockdown of
HNF4a in Caco-2 parental cells decreased the mRNA and protein
levels of claudin-1, occludin and ZO-1 in association with
disruption of the epithelial barrier function [63]. Thus, while
further experiments are needed to identify the exact molecular
mechanisms involved in this process, one could speculate that
PTEN controls intestinal barrier function by altering Cdx2 and
HNF4a expression and consequently, expression of tight junction
proteins. In this regard, PTEN activity has recently been shown to
induce an intestinal differentiation of gastric carcinomas by
increasing CDX2, claudin-3 and claudin-4 expression [57], hence
supporting this hypothesis.
Despite accumulating evidences showing a positive link between
low PTEN expression and intestinal transformation and cancer,
the specific involvement of loss of PTEN signaling in polarization,
tumorigenesis and metastasis of colonic cells remains elusive.
Colon cancer cells which contain mutant pi3kca and therefore
Figure 5. PTEN down-regulation increases metastatic potential of HCT116 and CT26 cells in vivo.A . Proliferating HCT116 cells expressing
shMUT or shPTEN were injected in the lateral tail-vein of 12 mice per condition. Mice injected with HCT116-expressing shPTEN developed tumors in
(various, multiple) locations such as the heart and dorsal muscle 50–75 days after tail-vein injection. T: tumor. B. CT26 cells were infected either with
recombinant lentiviruses encoding a shRNA which specifically knocked-down the murine form of PTEN (shPten) or with a negative control shRNA
(shTGFP). After selection of infected cells, proliferating cells were lysed and protein expression was analyzed by Western blot. Proliferating CT26 cells
expressing shTGFP or shPten were also injected in the lateral tail-vein of 6 mice per condition. Total number of detectable pulmonary metastasis was
evaluated 14 days after tail-vein injection. Significantly different at *** p#0.005.
doi:10.1371/journal.pone.0015742.g005
Figure 6. PTEN expression is decreased in colorectal cancers.
PTEN protein expression was investigated by Western blot in 53 paired
samples of colon cancers (resection margins and primary tumors).
Expression levels were normalized to the intensity of Ponceau red
staining and to a reference sample, resulting in a dimensionless value
(arbitrary units-AU). Amounts of PTEN protein in tumor tissues relative
to their matched normal samples were analyzed by paired t-test.
*** Significantly different at p#0.005.
doi:10.1371/journal.pone.0015742.g006
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cell growth and invasion [38]. Accordingly, the present results
show that PTEN silencing in Caco-2/15 and HCT116 colorectal
cancer cells significantly enhanced their capacity to form tumors in
vivo. We also found that reduction of PTEN expression in these
CRC cell lines induced their migration capacity in vitro probably
by promoting the activation of Rac and Cdc42. Indeed, although
many of the effects of PTEN on cell growth and survival are
believed to be mediated through its inhibition of PtdInsP3-
dependent protein kinase Akt [12], the effects of PTEN on cell
polarity and migration appear to be rather mediated through
other PtdIns(3,4,5)P3-dependent pathways, in particular, the small
GTPases of the Rac and Cdc42 families [37,45,46,64,65]. In the
present study, results revealed that PTEN silencing conferred
CRC cells with an enhanced invasive capacity to migrate in vitro
probably by inducing the expression of MMP-2, MMP-9 and uPA
as it has already been observed in prostate cancer cells [66]. These
effects of PTEN silencing are likely mediated by enhanced Akt
activity since downstream activation of Akt-dependent signaling
pathways has previously been shown to promote expression of
angiogenic and metastatic genes including uPA, COX2, MMP-2,
MMP-9 and osteopontin in CRC cell lines [67,68].
Loss of cell-cell adhesion followed by the dissociation of
epithelial structures is generally referred to as epithelial-mesen-
chymal transition (EMT). This phenotypic switch plays a
fundamental role in morphogenetic tissue remodeling during
embryogenesis. However, inappropriate reactivation of the EMT
program is commonly observed during transition of benign
adenomas to metastatic carcinomas [5]. Recently, Bowen et al.
[19] reported that PTEN knockdown increases migration and
invasion of the CRC cell lines HCT116 and SW480 which is
associated with change in E-cadherin expression, leading the
authors to conclude that PTEN loss induces cellular changes
consistent with EMT. Unfortunately, the expression of Snail1 and
Snail2 as well as the expression of other key markers of EMT such
as vimentin and N-cadherin were not analyzed in their study.
Furthermore, HCT116 and SW480 cell lines are not the most
accurate models to study EMT because they are not differentiated,
not polarized and do not exhibit typical and functional apical
junctional complexes. Data obtained in the present study suggest
that the downregulation of PTEN is not sufficient to trigger EMT-
like phenotype and metastatic properties in colorectal adenocar-
cinoma cells retaining significant cellular epithelial architecture
and polarity such as Caco-2/15 cells. Indeed, although PTEN
downregulation resulted in severe reduction of polarity associated
with a decrease in tight junction proteins, expression of
mesenchymal markers such as N-cadherin and vimentin was not
increased as confirmed by Western blot analysis (data not shown).
In addition, phase-contrast and electron microscopy analyses
demonstrated that Caco-2/15 cells containing a low level of PTEN
failed to acquire a fibroblastic or scattered morphology and
retained their capacity to form some cell-cell contacts. More
importantly, PTEN-deficient Caco-2/15 cells were not able to
form metastases when injected into the tail vein. This suggests that
PTEN silencing during CRC development may not be sufficient
for a complete loss of epithelial cell polarity and for cell
detachment. Interestingly, we [69] and others [70] have recently
reported that the conditional deletion of Pten in the mouse
intestinal epithelium was not sufficient to initiate tumor formation.
However, loss of Pten in the context of APC deficiency can lead to
the development of adenocarcinoma [70]. Therefore, additional
abnormalities must co-exist in addition to the loss of PTEN for
colon tumor cells to become fully invasive and metastatic. Such
phenomenon has previously been reported in the prostate where
loss of epithelial PTEN function leads to invasive lesions or even
metastasis only in combination with KRAS and SMAD4 mutations
[71]. Evidences from the literature suggest that KRAS may in fact
be a plausible candidate in CRC. Indeed, KRAS is mutated in
nearly 50% of tumors at a relatively early stage of the carcinogenic
process [72]. Furthermore, recent studies indicate that KRAS
signaling contributes to metastasis formation in CRC [73–75]. Of
note, Caco-2 cells do not carry mutations in either KRAS or BRAF
genes [25] whereas CT26 and HCT116 cells exhibit an activating
mutation in codons 12 and 13 respectively of the KRAS proto-
oncogene [26,29]. Inhibition of the KRAS downstream effectors,
MEK1/2, in CRC cell lines carrying activating KRAS mutations
(HCT116, DLD1, LoVo, SW480) has also been shown to inhibit
expression of Snail1 and Snail2 [75], indicating that expression of
these key EMT factors is likely dependent on KRAS signaling in
these cell lines. Snail1 and Snail2 transcription factors are the
major proteins implicated in repression of E-cadherin, which is the
key molecular change occurring during EMT [5]. Moreover, the
reduction and loss of E-cadherin expression has been reported in
advanced colorectal carcinomas [6] and has been considered to
augment cellular dissemination and tumor metastasis [76]. Of
particular interest, experiments conducted to silence the expres-
sion of E-cadherin not only showed a morphological shift from an
epithelial to a fibroblastoid phenotype, characteristic of EMT, but
also a concomitant increase in invasive cell behavior [5]. In
keeping with this observation, we (data not shown) and others [30]
demonstrated that CT26 cells do not express E-cadherin while
HCT116 cells express considerably less E-cadherin in comparison
to Caco-2/15 cells. Hence, loss of E-cadherin also appears to be a
prerequisite for tumor progression and not just a consequence of
tumor dedifferentiation.
In summary, the present studies performed in colorectal cancer
cells demonstrate that the expression level of PTEN may have a
profound influence on the susceptibility of tumor cells to polarize,
migrate, invade and metastasize. However, our results also suggest
that reduction of PTEN during the development of intestinal
epithelial-derived tumors is not sufficient by itself to induce EMT
and metastasis. The large number of processes affected by PTEN
downregulation could explain the association between low PTEN
expression and poor prognosis in colorectal cancer patients
[16,41,77], although we and others did not find any significant
relation between PTEN expression and grade or stage of colorectal
cancers (our results and [15]). We could not exclude however that
the phosphatase activity of PTEN might be further inhibited by
other mechanisms such as PTEN phosphorylation, ubiquitination,
acetylation or oxidation [9] in late stages of carcinogenesis. This
strengthens the need to understand the cellular mechanisms by
which PTEN phosphatase activity is controlled. Together with the
accumulating evidence that loss of cellular polarity and tissue
architecture can be the driving force in tumor progression rather
than its by-product [78], the current data indicate that studies
pertaining to PTEN in epithelial biology may be highly relevant to
the tumor suppressor functions of PTEN.
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